Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (231-240 of 421) with videos related to

Pageof 43
Sort By:
Thrombosis Research|January 23, 2018
Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort studyNick van Es, Martha Louzada, Marc Carrier, et al.
Journal of Thrombosis and Thrombolysis|February 5, 2021
Clinical and sociodemographic factors associated with anticoagulant use for cancer associated venous thromboembolismJordan K Schaefer, Mengbing Li, Zhenke Wu, et al.
Journal of Surgical Oncology|January 23, 2014
Vascular progenitor clusters from peripheral blood in cancer patients following oncologic surgeryHedyeh Javidnia, Mary Hanna, Yuhua Li, et al.
Inflammatory Bowel Diseases|January 30, 2020
Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based StudyJeffrey D McCurdy, M Ellen Kuenzig, Glenys Smith, et al.
Journal of Thrombosis and Haemostasis : JTH|July 5, 2019
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer studyMarcello Di Nisio, Nick van Es, Marc Carrier, et al.
Research and Practice in Thrombosis and Haemostasis|July 3, 2025
Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trialTzu-Fei Wang, Mari Thomas, Andrea Cervi, et al.
Thrombosis Research|June 6, 2022
Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT TrialWillem Brandt, Cameron Brown, Tzu-Fei Wang, et al.
Thrombosis Research|February 5, 2017
Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolismKathryn Coyle, Marc Carrier, Alejandro Lazo-Langner, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2022
Step down to 6 months of prophylactic-dose low molecular weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): A pilot studyJesse Popov, Suellen Coelho, Marc Carrier, et al.
International Journal of Environmental Research and Public Health|July 24, 2021
A Health eLearning Ontology and Procedural Reasoning Approach for Developing Personalized Courses to Teach Patients about Their Medical Condition and TreatmentMartin Michalowski, Szymon Wilk, Wojtek Michalowski, et al.
Pageof 43

Showing results (231-240 of 421) with videos related to

Sort By:
Pageof 43
Thrombosis Research|January 23, 2018
Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort studyNick van Es, Martha Louzada, Marc Carrier, et al.
Journal of Thrombosis and Thrombolysis|February 5, 2021
Clinical and sociodemographic factors associated with anticoagulant use for cancer associated venous thromboembolismJordan K Schaefer, Mengbing Li, Zhenke Wu, et al.
Journal of Surgical Oncology|January 23, 2014
Vascular progenitor clusters from peripheral blood in cancer patients following oncologic surgeryHedyeh Javidnia, Mary Hanna, Yuhua Li, et al.
Inflammatory Bowel Diseases|January 30, 2020
Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based StudyJeffrey D McCurdy, M Ellen Kuenzig, Glenys Smith, et al.
Journal of Thrombosis and Haemostasis : JTH|July 5, 2019
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer studyMarcello Di Nisio, Nick van Es, Marc Carrier, et al.
Research and Practice in Thrombosis and Haemostasis|July 3, 2025
Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trialTzu-Fei Wang, Mari Thomas, Andrea Cervi, et al.
Thrombosis Research|June 6, 2022
Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT TrialWillem Brandt, Cameron Brown, Tzu-Fei Wang, et al.
Thrombosis Research|February 5, 2017
Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolismKathryn Coyle, Marc Carrier, Alejandro Lazo-Langner, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2022
Step down to 6 months of prophylactic-dose low molecular weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): A pilot studyJesse Popov, Suellen Coelho, Marc Carrier, et al.
International Journal of Environmental Research and Public Health|July 24, 2021
A Health eLearning Ontology and Procedural Reasoning Approach for Developing Personalized Courses to Teach Patients about Their Medical Condition and TreatmentMartin Michalowski, Szymon Wilk, Wojtek Michalowski, et al.
Pageof 43